The Future of Community and Mobility Week
Reimagining healthy ageing: Transforming care pathways
EXPO 2025 Thematic Project " Resonance of Lives " (Producer MIYATA Hiroaki)
With an aging population, non-communicable diseases (NCDs) such as cancer, cardiovascular diseases, and respiratory disease have become significant challenges. To extend healthy life expectancy, a transforming care pathways is required to address the various challenges surrounding these NCDs. This event aims to share exemplary initiatives, discuss challenges and solutions, and explore pathways toward transforming healthcare systems for a better future.
Discussion
| Transmission of simultaneous interpretation | Provided |
|---|---|
| Language of interpretation | Japanese and English |
Reservations are required for this programme.
Booking typically opens with the '2-month advance lottery.' Click below for details.
* Arrive early; latecomers may not be admitted.
For more information about making a reservation to watch a programme.
Please watch the Virtual Studio if you are outside the venue.
-
Signature Programme
- * Programme times and content are subject to change. Any changes will be announced on this website and via the ticket booking system.
- * The schedule is subject to change depending on the organiser's circumstances.
- Time and
Date of
the event -
-
2025.05.15[Thu]
15:00 ～ 19:30
(Venue Open 14:30)
-
- Venue
- Theme Weeks Studio
Programme details
With the advancement of an aging society, non-communicable diseases (NCDs) such as cancer, cardiovascular diseases, and respiratory disease have become significant challenges for society. To extend healthy life expectancy, a transforming care pathways is required to address the various issues surrounding these NCDs. This event will share excellent initiatives leading to change both overseas and domestically, focusing on COPD among respiratory diseases, and will explore the future of healthcare systems that can diagnose and prevent the progression of NCDs while discussing current issues and solutions, including the recently revealed relationship with cardiovascular disease.
Cast
Moderator
Hiroaki Miyata
Professor, Health Policy and Management, Keio University
View Profile
Close
close
Stefan Weber
Vice president Global Policy, Advocacy, Health Equity AstraZeneca
View Profile
Close
close
Ryoji Noritake
Chair, Health and Global Policy Institute
View Profile
Close
close
Taku Iwami
Professor, Graduate School of Medicine, School of Public Health, Department of Preventive Services
View Profile
Close
close
Speakers
Ruud Dobber
EVP Biopharmaceuticals Business AstraZeneca
View Profile
Close
close
Alexander de Giorgio-Miller
Senior vice president Global Medical BioPharmaceuticals AstraZeneca
View Profile
Close
close
Stephen Holt
Professor Director and CEO of SEHA Kidney Care, UAE
View Profile
Close
close
Heinrich Worth
Pneumological and Cardiological Practice, Germany
View Profile
Close
close
George Wharton
Associate Professor of Health Policy, London School of Economics, UK
View Profile
Close
close
Pan-Chyr Yang
Chair Professor, National Taiwan University College of Medicine, Taiwan
View Profile
Close
close
Akihito Yokoyama
Member of the MHLW's Next National Health Promotion Plan (starting in FY2024) Development Committee/Advisor and Director, Respiratory and Allergy Center, Matsuyama City Hospital/Professor Emeritus, Kochi University
View Profile
Close
close
Yuji Furui
Project Professor, Institute for Future Initiatives, The University of Tokyo/Visiting Professor, Jichi Medical University
View Profile
Close
close
Shigeo Muro
Professor, Department of Respiratory Medicine, Nara Medical University
View Profile
Close
close
Koichiro Kuwahara
Professor, Department of Cardiovascular Medicine, Shinshu University School of Medicine
View Profile
Close
close
Gen Nakagawa
Mayer of Nara city
View Profile
Close
close
Eiyasu Tsuboi
Vice President, Fukushima Medical Association/President, Koriyama Medical Association
View Profile
Close
close
Takafumi Horii
SVP Japan Country President AstraZeneca
View Profile
Close
close
Co-organiser
AstraZeneca K.K.
The Future of Community and Mobility Week
Reimagining healthy ageing: Transforming care pathways
With an aging population, non-communicable diseases (NCDs) such as cancer, cardiovascular diseases, and respiratory disease have become significant challenges. To extend healthy life expectancy, a transforming care pathways is required to address the various challenges surrounding these NCDs. This event aims to share exemplary initiatives, discuss challenges and solutions, and explore pathways toward transforming healthcare systems for a better future.
-
2025.05.15[Thu]
15:00～19:30
(Venue Open 14:30)
- Theme Weeks Studio
- * Programme times and content are subject to change. Any changes will be announced on this website and via the ticket booking system.
- * The schedule is subject to change depending on the organiser's circumstances.
Reservations are required for this programme.
Booking typically opens with the '2-month advance lottery.' Click below for details.
* Arrive early; latecomers may not be admitted.
For more information about making a reservation to watch a programme.
Please watch the Virtual Studio if you are outside the venue.
OTHER PROGRAM
The Future of Community and Mobility Week
